King Pharmaceuticals, the world's 39th better biologic company, is based in Bristol, Tennessee. King produces a advanced ambit of pharmaceuticals, including Altace for affection advance prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a beef relaxant. King Pharmaceuticals currently operates accomplishment accessories in Bristol, Tennessee, Rochester, Michigan, St. Louis, Missouri, St. Petersburg, Florida, and Middleton, Wisconsin, and they apply about 2700 humans including a sales force of over 1000 individuals.
Pfizer, the world’s largest drug company by revenues, has agreed to buy King Pharmaceuticals, a maker of prescription pain treatments, for $3.6bn in cash as it seeks to diversify its portfolio before it loses patent protection on key drugs. Pfizer will pay $14.25 a share, a 40 per cent premium over King’s closing share price, valuing the company at about seven times earnings before interest, tax, depreciation and amortisation.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment